Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-22

FDA Approved: RAMELTEON — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves the original ANDA for ramelteon from Zydus Pharmaceuticals USA Inc., enabling a generic version of this insomnia medication. Ramelteon is used for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramelteon (ramelteon)

Snippet

ORIG AP for RAMELTEON (RAMELTEON)